The study of hepatitis B and hepatitis C infection in patients and healthy blood donors
Journal Title: International Journal of Medical and Health Research - Year 2017, Vol 3, Issue 1
Abstract
Introduction:Safe blood and blood products should be offered to all patients in need for blood transfusion. The objectives of the present study were to establish prevalence estimates for hepatitis B and hepatitis C virus infections as a foundation for safe blood transfusion in hospital, and to check the accuracy of the laboratory analysis used for hepatitis testing of blood donors in hospital. Methods: A total of 1, 200 blood samples collected from potential blood donors were tested by an enzyme immunoassay technique (EIA) for detection of hepatitis surface antigen (HBsAg), antibodies to hepatitis B core antigen (anti-HBc), and antibodies to hepatitis C antigen (anti-HCV). The EIA test outcome was validated by a chemiluminescent micro particle immunoassay technique (CMIA). Results: The prevalence of HBsAg and anti-HBc in the study population was 11.4 per cent (95% CI 9.6 - 13.2) and 51.7 per cent (95% CI 48.8 - 54.5), respectively, the prevalences being higher in males than females. The prevalence of anti-HCV was 0.17 per cent. The test agreement between the EIA and CMIA techniques was high both for HBsAg detection (κ = 0.91; 95% CI: 0.83 - 0.99) and for anti-HBc detection (κ = 0.89; 95% CI 0.81 - 0.97). Compared to CMIA results, the positive and negative predictive values of the EIA tests were found to be 94.9 per cent (95% CI 87.5 - 98.6) and 97.5 per cent (95% CI 86.8 - 99.9) for HBsAg, and 92.4 per cent (95% CI 84.2 - 97.2) and 100 per cent (95% CI 91.2 - 100) for anti-HBc. Interpretation & conclusions: The study shows that hepatitis B virus infection is endemic in local area and that almost population is or has been infected. Hepatitis C infection is rare, but false negative test results cannot be ruled out. Also, the results indicate that the EIA performance in blood donor screening may be sub-optimal, missing 2.5 per cent of hepatitis B virus carriers and falsely excluding more than 7 per cent of blood donors. As the prevalence of hepatitis B infection is high, occult hepatitis B infection may represent a threat to safe blood transfusion. Therefore, nucleic acid amplification testing for HBV should be considered for blood donor screening.
Authors and Affiliations
Dr. Shamim Ahmad, Dr. Ahsan Hamidi
Keywords
Related Articles
- EP ID EP582403
- DOI -
- Views 142
- Downloads 0
Incidence of acute intestinal obstruction in adults in eastern India
This observational study was conducted in rural based medical college of Bihar, during the period September 2014 to June 2015. The aim was to know the prevalence and other related aspects of acute intestinal obstruction...
Comparison of ultrasonographic and Doppler mapping of the intervillous circulation in normal and abnormal early pregnancies
There has been increased in studying the development of Intervillous circulation during early pregnancy gestation, made possible by the availability of using transvaginal ultrasound and transvaginal colour Doppler imagin...
Utility of cranial ultrasonography in preterm and critically ill neonates
Neonatal care in India is advancing at an impressive phase at the level of the community as well as in tertiary care units. Concept of “survival” of newborn has given way to “intact survival” of the high risk newborn emp...
Comparative evaluation of Diclofenac with Paracetamol for post-operative analgesia following laparoscopic cholecystectomy
The use of IV Paracetamol or IV Diclofenac as analgesia, using an opioid as rescue analgesic only when needed, would reduce the amount of opioid used and ensure a comfortable postoperative recovery period. Hence the prop...
Acute effect of examination stress on cardiovascular parameters
Medical students, particularly the first year students who are in the transition phase of their life, are the most vulnerable for developing stress. Many researchers have reported a relationship between stress and blood...